EN

Vote in the European Parliament

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

Tomislav Sokol – Article 16, after § 2 – Am 250
Date: 20.01.2026·Reference: A10-0272/2025
Rapporteur: Tomislav Sokol
public healthcrisis managementinvestmentstrategic autonomymedicinal productsupply chainsecurity of supplypublic procurementEU productionenvironmental impactshortagepharmaceutical legislation

Overall Result

Rejected
  • 141 For
  • 516 Against
  • 7 Abstention
  • 55 Did not vote
Amendment— You are viewing a sub-vote (amendment) of the main vote.Amendment 250 · Draft legislative act · Tabled by The LeftView amendment at the EP ↗
Amendment wording

Tabled by Anthony Smith, Catarina Martins

Added: 2 a. Undertakings benefiting from Union funding must comply with sectorial collective agreements, offer good working conditions and decent wages. They shall not be allowed to distribute excessive dividends, resort to tax heavens, or proceed with collective layoffs and shall reimburse public funding received in case of non-compliance with their obligations. They shall also comply with their obligations related to social and environmental reporting. Undertakings that do not comply with labour law and health and safety regulations shall not be able to benefit from direct public subsidies and shall be excluded from public procurement tendering procedures.

Wording as published by the EP, in English. PE781.998

← Back to Main Vote
Status and procedure

Outcome as recorded by the European Parliament.

Vote held on
Latest recorded step
Committee stage · (122 days ago)
Next scheduled step
Plenary · (in 12 days)

Procedure timeline

2025/0102(COD) · COD

Recorded procedure activities. These do not establish whether a law has entered into force.

  1. Recorded: Referral58 days until the next step
  2. Recorded: Committee stage154 days until the next step
  3. Recorded: Plenary32 days until the next step
  4. Recorded: Negotiations175 days until the next step
  5. Latest recorded: Committee stage122 days since this step began
  6. Planned: Plenary
Recorded activities (25)
  1. Referral to committee
  2. Committee report tabled
  3. Committee amendments tabled
  4. Committee amendments tabled
  5. Committee amendments tabled
  6. Committee opinion adopted
  7. Committee opinion adopted
  8. Committee opinion adopted
  9. Committee report adopted
  10. Tabling for plenary
  11. Tabling for plenary
  12. Tabling for plenary
  13. Tabling for plenary
  14. Tabling for plenary
  15. Tabling for plenary
  16. Tabling for plenary
  17. Plenary debate
  18. Text amended in plenary
  19. Referred back to committee for interinstitutional negotiations
  20. Plenary vote
  21. Plenary vote results
  22. Interinstitutional negotiations
  23. Interinstitutional negotiations
  24. Interinstitutional negotiations
  25. Provisional agreement approved in committee
Scheduled activities (not confirmation of completion)
  1. Plenary debate
  2. Plenary vote
  3. Plenary vote

Procedure file (OEIL) · European Parliament data
Retrieved:

Sources

Roll-call minutesParliament documentProcedure file (OEIL)

Data: EP Open Data API

What is this about?

  • This regulation seeks to enhance the security of supply and availability of critical medicines across the EU.
  • It establishes a framework to diversify supply chains and incentivize investments in local manufacturing capacities.
  • Special focus is placed on older, off-patent drugs through targeted financial support and streamlined approval processes.
  • Coordination among member states aims to reduce market fragmentation and strengthen the internal market.
  • The goal is to bolster the EU’s strategic autonomy in the healthcare sector.
Source: Explanatory Statement (AI Generated)

Vote by political group

How the political groups voted

Non-attached Members (NI)
For17
  • 17For
  • 7Against
  • 2Abstention
  • 4Did not vote
View details
The Left in the European Parliament (GUE/NGL)
For39
  • 39For
  • 0Against
  • 0Abstention
  • 7Did not vote
View details
Progressive Alliance of Socialists and Democrats (S&D)
For32
  • 32For
  • 91Against
  • 2Abstention
  • 11Did not vote
View details
Greens/European Free Alliance (Greens/EFA)
For51
  • 51For
  • 0Against
  • 0Abstention
  • 2Did not vote
View details
European People's Party (EPP)
For1
  • 1For
  • 181Against
  • 0Abstention
  • 6Did not vote
View details
Renew Europe (Renew)
For1
  • 1For
  • 66Against
  • 1Abstention
  • 7Did not vote
View details
Patriots for Europe (PfE)
For0
  • 0For
  • 78Against
  • 0Abstention
  • 7Did not vote
View details
European Conservatives and Reformists (ECR)
For0
  • 0For
  • 70Against
  • 1Abstention
  • 8Did not vote
View details
Europe of Sovereign Nations (ESN)
For0
  • 0For
  • 23Against
  • 1Abstention
  • 3Did not vote
View details

Members

Showing 10 of 719

Vote Position
NameCountryGroupVote Position
Kathleen FunchionKathleen Funchion
IrelandGUE/NGL
For
Thomas Pellerin-CarlinThomas Pellerin-Carlin
FranceS&D
For
Gordan BosanacGordan Bosanac
CroatiaGreens/EFA
For
Ilaria SalisIlaria Salis
ItalyGUE/NGL
For
Manuela RipaManuela Ripa
GermanyEPP
For
Adnan DibraniAdnan Dibrani
SwedenS&D
For
Rima HassanRima Hassan
FranceGUE/NGL
For
Elisabeth GrossmannElisabeth Grossmann
AustriaS&D
For
Nikolas FarantourisNikolas Farantouris
GreeceGUE/NGL
For
Fabio De MasiFabio De Masi
GermanyNI
For
Show more
← Go back
Follow us on Instagram@checksomevotes@checksomevotes_en